Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Skin Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostics and Treatment Market Perspective (2017-2028)
2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Region
2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Size by Region (2017-2022)
2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Region (2023-2028)
2.3 Tuberculosis Diagnostics and Treatment Market Dynamics
2.3.1 Tuberculosis Diagnostics and Treatment Industry Trends
2.3.2 Tuberculosis Diagnostics and Treatment Market Drivers
2.3.3 Tuberculosis Diagnostics and Treatment Market Challenges
2.3.4 Tuberculosis Diagnostics and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2017-2022)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
3.4 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2021
3.5 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostics and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnostics and Treatment Breakdown Data by Type
4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2017-2022)
4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2023-2028)
5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application
5.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2017-2022)
5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
6.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type
6.2.1 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
6.2.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
6.2.3 North America Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application
6.3.1 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
6.3.2 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
6.3.3 North America Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Country
6.4.1 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
6.4.2 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type
7.2.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
7.2.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
7.2.3 Europe Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application
7.3.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
7.3.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
7.3.3 Europe Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Country
7.4.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
7.4.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
9.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type
9.2.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
9.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application
9.3.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
9.4 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country
9.4.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cepheid Inc
11.1.1 Cepheid Inc Company Details
11.1.2 Cepheid Inc Business Overview
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
11.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.1.5 Cepheid Inc Recent Developments
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Details
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
11.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.2.5 Becton Dickinson Recent Developments
11.3 Hain LifeSciences
11.3.1 Hain LifeSciences Company Details
11.3.2 Hain LifeSciences Business Overview
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
11.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.3.5 Hain LifeSciences Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
11.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.4.5 Abbott Laboratories Recent Developments
11.5 Alere, Inc
11.5.1 Alere, Inc Company Details
11.5.2 Alere, Inc Business Overview
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
11.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.5.5 Alere, Inc Recent Developments
11.6 Roche AG
11.6.1 Roche AG Company Details
11.6.2 Roche AG Business Overview
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
11.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.6.5 Roche AG Recent Developments
11.7 Hologic Corporation
11.7.1 Hologic Corporation Company Details
11.7.2 Hologic Corporation Business Overview
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
11.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.7.5 Hologic Corporation Recent Developments
11.8 bioMerieux
11.8.1 bioMerieux Company Details
11.8.2 bioMerieux Business Overview
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
11.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.8.5 bioMerieux Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
11.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.9.5 Sanofi Recent Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.10.5 QIAGEN Recent Developments
11.11 Akonni Biosystems, Inc.
11.11.1 Akonni Biosystems, Inc. Company Details
11.11.2 Akonni Biosystems, Inc. Business Overview
11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
11.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.11.5 Akonni Biosystems, Inc. Recent Developments
11.12 Epistem Holdings Plc
11.12.1 Epistem Holdings Plc Company Details
11.12.2 Epistem Holdings Plc Business Overview
11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
11.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.12.5 Epistem Holdings Plc Recent Developments
11.13 Gen-Probe Inc.
11.13.1 Gen-Probe Inc. Company Details
11.13.2 Gen-Probe Inc. Business Overview
11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
11.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.13.5 Gen-Probe Inc. Recent Developments
11.14 EIKEN Chemical
11.14.1 EIKEN Chemical Company Details
11.14.2 EIKEN Chemical Business Overview
11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
11.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.14.5 EIKEN Chemical Recent Developments
11.15 Thermo Fisher Scientific, Inc
11.15.1 Thermo Fisher Scientific, Inc Company Details
11.15.2 Thermo Fisher Scientific, Inc Business Overview
11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
11.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.15.5 Thermo Fisher Scientific, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer